Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment

Ann Rheum Dis. 2009 Jul;68(7):1235-6. doi: 10.1136/ard.2008.099267.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloidosis / drug therapy*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • Colonic Diseases / drug therapy*
  • Female
  • Humans
  • Ileal Diseases / drug therapy*
  • Middle Aged
  • Receptors, Interleukin-6

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Receptors, Interleukin-6
  • tocilizumab